ExploreWatchlistsPricing
  1. JP-listed companies
  3. Financials
  4. Revenue growth (%)

(4881)

Market cap
¥2.9B
P/E ratio
Funpep develops new medicines using functional peptides and its STEP UP drug discovery platform, focusing on treatments like SR-0379 for skin ulcers.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndRevenue growth (%) YoY (%)
Dec 31, 2025-94.9-108.98%
Dec 31, 20241,056-2198.23%
Dec 31, 2023-50.3-49.24%
Dec 31, 2022-99.2-102.38%
Dec 31, 20214,171.7-4313.39%
Dec 31, 2020-99+547.12%
Dec 31, 2019-15.3-106.08%
Dec 31, 2018251.7-421.97%
Dec 31, 2017-78.2-147.38%
Dec 31, 2016165

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat